CSBR (Champions Oncology, Inc.) Stock Analysis - Analyst Ratings

Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CSBR?

The average price target is $0.00.

CSBR Key Metrics

Key financial metrics for CSBR
MetricValue
Price$5.99
Market Cap$84.29M
P/E Ratio17.65
EPS$0.34
Dividend Yield0.00%
52-Week High$11.99
52-Week Low$3.75
Volume0
Avg Volume0
Revenue (TTM)$56.94M
Net Income$4.70M
Gross Margin50.15%

CSBR Analyst Consensus

CSBR analyst coverage data. Average price target: $0.00.

Latest CSBR News

Recent CSBR Insider Trades

  • Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
  • Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
  • Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.

Common questions about CSBR

What do analysts rate CSBR?
The average price target is $0.00.
Does Rallies show CSBR price targets?
Yes. Rallies tracks CSBR analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CSBR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.
CSBR

CSBR